Consistency of response to sumatriptan/naproxen sodium in a placebo-controlled cross-over study.
Torgovnick
Josh
J
Sethi
Nitin K
NK
Arsura
Edward
E
D016265:Conflict of Interest; D018592:Cross-Over Studies; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D009288:Naproxen / Q000008:administration & dosage*; D010919:Placebos; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage*; D018170:Sumatriptan / Q000008:administration & dosage*
D016861:Cyclooxygenase Inhibitors; D010919:Placebos; D017366:Serotonin Receptor Agonists; D009288:Naproxen; D018170:Sumatriptan